NAMS MENOPAUSE CERTIFICATION EXAM QUESTIONS WITH CORRECT ANSWERS 2026

NAMS MENOPAUSE CERTIFICATION EXAM QUESTIONS WITH
CORRECT ANSWERS 2026


-VCORRECTVANSWERSV-
TheVperiodVofVendrocrinologic,Vsomatic,VandVtransitoryVpsychologicVchangesVthatVoccurVaroundVt
heVtimeVofVmenopause.



EarlyVmenopauseV-VCORRECTVANSWERSV-LMPVbeforeVageV45



LateVmenopauseV-VCORRECTVANSWERSV-LMPVafterVageV54



PrimaryVovarianVinsufficiencyV-VCORRECTVANSWERSV-MenopauseVthatVoccursVbeforeVageV40



EarlyVmenopauseVtransitionV(stageV-2)V-VCORRECTVANSWERSV-
PersistentVdifferenceVofV7VdaysVorVmoreVinVtheVlengthVofVconsecutiveVcycles.



LateVmenopauseVtransitionV(stageV-1)V-VCORRECTVANSWERSV-
60VorVmoreVconsecutiveVdaysVofVamenorrhea



LutealVoutVofVphaseVeventV(LOOP)V-VCORRECTVANSWERSV-
ExplainsVwhyVsomeVperimenopausalVwomenVhaveVelevatedVestrogenVlevelVsometimes...InVtheVear
lyVmenopauseVtransition,VelevatedVFSHVlevelsVareVadequateVtoVrecruitVaVsecondVfollicleVwhichVres
ultsVinVaVfollicularVphase-likeVriseVinVestradiolVsecretionVsuperimposedVonVtheVmid-to-
lateVlutealVphaseVofVtheVongoingVovulatoryVcycle.



ObeseVwomenVandVestradiolVlevelsVduringVmenopauseV-VCORRECTVANSWERSV-
ObeseVwomenVareVmoreVlikelyVtoVhaveVanovulatoryVcyclesVwithVhighVestradiolVlevels.VTheyVareVals
oVmoreVlikelyVtoVhaveVlowerVpremenopauseVyetVhigherVpostmenopauseVestradiolVlevelsVcompare
dVwithVwomenVofVnormalVweight.V(whyVtheyVareVatVhigherVriskVofVendometrialVcancer)

,ChineseVandVJapaneseVwomenV-VCORRECTVANSWERSV-
TheseVethnicVgroupsVhaveVlowerVestradiolVlevelsVthenVwhite,VblackVandVhispanicVwomen.



stageV+2V-VCORRECTVANSWERSV-lateVmenopauseVstage:V5-
8VyearsVafterVFMP.VSomaticVagingVpredominates.VIncreasedVgenitourinaryVsymptoms.



StagesV+1a,V+1b,V+1cV-VCORRECTVANSWERSV-
earlyVpostVmenopause:V2VyearsVafterVFMP.VFSHVrises,VestradiolVdecreases.VVMSVpredominate.



ElevatedVFSH,VLHV-VCORRECTVANSWERSV-EndocrineVlabsVafterVmenopause



AMH,VinhibinVBV-VCORRECTVANSWERSV-
TheseVhormonesVworkVduringVreproductiveVyearsVtoVnotVdepleteVfollicleVpoolVtooVquickly.



PhasesVduringVmenopauseVtransitionVandVPMSVsymptomsV-VCORRECTVANSWERSV-
MenstrualVcycleVshortenes,VfollicularVphaseVcompresses,VwomenVspendVmoreVtimeVinVlutealVphas
e..VmeaningVmoreVpremenstrualVsymptomsVandVmoreVfrequentVmenstrualVperiods.



HowVtoVrespondVifVaVpatientVrequestsVFSHVlab?V-VCORRECTVANSWERSV-
manyVpitfalls,VvariableVdependingVonVtheVdayVofVtheVcycleVyouVdrawVtheVlab,VnormalVorVlowVFSHVis
VnotVhelpful.




TheVpotentiallyVsuperiorVmarkerVofVmenopause,VaVlab.V-VCORRECTVANSWERSV-AMH



DHEAV(dehydroepiandrosterone)V-VCORRECTVANSWERSV-
AdrenalVandrogens:VprecursorVhromonesVproducedVbyVtheVadrenalVglandVthatVareVenzymaticallyVc
onvertedVtoVactiveVandrogensVorVestrogensVinVperipheralVtissues.

, LocationVofVestrogenVreceptorsV-VCORRECTVANSWERSV-
Vagina,Vvulva,Vurethra,VtrigoneVofVtheVbladder



EffectsVofVestrogenVonVtissueV-VCORRECTVANSWERSV-
maintainVbloodVflow,VtheVcollagen,VandVHAVwithinVtheVepithelialVsurfaces.VSupportsVmicrobiomeVa
ndVprotectsVtissueVfromVpathogens.



VaginalVchangesVwithVmenopauseV-VCORRECTVANSWERSV-
Thinning,VlossVofVelasticity,VlossVorVabsenceVorVrugae.



VaginaVandVurethraVinVmenopauseV-VCORRECTVANSWERSV-
vaginaVnarrows,VurethraVmovesVcloserVtoVtheVintroitus.



StressVurinaryVincontinenceV-VCORRECTVANSWERSV-
VaginalVestrogenVandVurinaryVincontinence:VwhatVtypeVdoesVitVhelpVwith?



TreatmentVforVFPHLV-VCORRECTVANSWERSV-
Minoxidil,Vspironolactone,Vfinasteride,VestrogenVtherapy



LateVreporoductiveVyearsV-3bVandV-
3a.VWhatVhappensVwithVmenstrualVcycles,VFSH,VAMH,VAFC,Vinhibin?V-VCORRECTVANSWERSV--
3b:VmenstrualVcyclesVnormal,VFSHVnormal,VAMHVlow,VAFCVlow,VinhibinVlow.V



-3a:VsubtleVmenstrualVchanges,VvariableVFSH,VAMHVlow,VAFCVlow,VinhibinVlow.



WhenVitVisVappropriateVtoVcheckVanVFSHVduringVtheVcycleVifVyouVcheckVit?VandVwhy?V-
VCORRECTVANSWERSV-


CycleVdayV#3.VElevatedVestradiolVcanVsuppressVFSHVgivingVaVfalselyVnormalVFSHVlevel.